Stocktoria
ORASURE TECHNOLOGIES INC OSUR
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1986-11-17
ORASURE TECHNOLOGIES INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 41.9% | 42.7% | 42.3% | 38.3% | 50.3% |
| Operating margin | -62.6% | -15.2% | 8.1% | -5.7% | -4.3% |
| Net margin | -59.8% | -10.5% | 13.2% | -4.4% | -9.8% |
| FCF margin | -46.3% | 12.7% | 33.5% | -13.9% | -24.5% |
| Return on assets | -17.0% | -4.1% | 11.1% | -3.9% | -5.0% |
| Return on equity | -20.2% | -4.8% | 12.5% | -4.7% | -6.0% |
| Current ratio | 6.58 | 9.95 | 9.77 | 4.71 | 4.40 |
| Revenue growth | -38.1% | -54.2% | 4.6% | 65.8% | 36.1% |
Source: SEC EDGAR filings · CIK 0001116463 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.